EDIT vs SOFI · rev $32.3M vs P/E 39, rev $619.4M
Editas Medicine Inc (EDIT) versus SoFi Technologies Inc. (SOFI) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
SoFi Technologies Inc. (SOFI) is a credit services company listed on NASDAQ.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported SOFI revenue for 2025-12-31 was $619.4M. Net income was $481.3M. Revenue was up 23.1% from 2024-12-31 to 2025-12-31. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
EDIT currently screens at market cap $375.2M. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
Not investment advice. Open the EDIT and SOFI stock pages for the full models.
Not investment advice.